{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:41:38Z","timestamp":1770136898347,"version":"3.49.0"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/ico.0b013e318041f0c0","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T14:32:33Z","timestamp":1473258753000},"page":"641-642","source":"Crossref","is-referenced-by-count":20,"title":["Herpes Simplex Keratitis After Intravitreal Triamcinolone Acetonide"],"prefix":"10.1097","volume":"26","author":[{"given":"Roni M","family":"Shtein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roslyn M","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Saxe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzad I","family":"Mian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-29-20210204","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000093796","article-title":"Intravitreal triamcinolone acetonide: a change in a paradigm.","volume":"38","author":"Jonas","year":"2006","journal-title":"Ophthalmic Res"},{"key":"R2-29-20210204","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0008-4182(05)80119-X","article-title":"Complications of intravitreal injection of triamcinolone acetonide.","volume":"40","author":"Ozkiris","year":"2005","journal-title":"Can J Ophthalmol"},{"key":"R3-29-20210204","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0039-6257(78)90197-2","article-title":"Glucocorticoid therapy in ocular herpes simplex. I. Limitations.","volume":"23","author":"Ostler","year":"1978","journal-title":"Surv Ophthalmol"},{"key":"R4-29-20210204","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0039-6257(91)90184-H","article-title":"Herpes simplex keratitis: role of viral infection versus immune response.","volume":"35","author":"Pepose","year":"1991","journal-title":"Surv Ophthalmol"},{"key":"R5-29-20210204","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM199807303390503","article-title":"Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group.","volume":"339","author":"Baron","year":"1998","journal-title":"N Engl J Med"},{"key":"R6-29-20210204","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.ophtha.2005.07.014","article-title":"Herpetic eye disease in diabetic patients.","volume":"112","author":"Kaiserman","year":"2005","journal-title":"Ophthalmology"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e318041f0c0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:27:47Z","timestamp":1621884467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-200706000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318041f0c0","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}